Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Abcellera Biologics Inc (NQ: ABCL ) 2.730 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,268,202 Open 2.740 Bid (Size) 2.750 (1) Ask (Size) 2.800 (45) Prev. Close 2.730 Today's Range 2.715 - 2.800 52wk Range 2.335 - 6.055 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News AbCellera to Present at Upcoming Investor Conferences in November 2024 October 22, 2024 From AbCellera Biologics Inc. Via Business Wire AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024 October 04, 2024 From AbCellera Biologics Inc. Via Business Wire Performance YTD -52.36% -52.36% 1 Month +9.20% +9.20% 3 Month -1.09% -1.09% 6 Month -33.58% -33.58% 1 Year -38.99% -38.99% More News Read More AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024 September 26, 2024 From AbCellera Biologics Inc. Via Business Wire AI-Focused Drug Discovery Stocks +6% Last Week Vs. -8% Previous Week September 15, 2024 Via Talk Markets AI-Focused Drug Discovery Stocks Portfolio -8% W/e Sept 6th September 10, 2024 Via Talk Markets Our AI-Focused Drug Discovery Stocks Portfolio Down 8% In August; Down 6.7% Yesterday Alone! September 05, 2024 Via Talk Markets Topics Economy Exposures Economy AbCellera to Present at Upcoming Investor Conferences in September August 29, 2024 From AbCellera Biologics Inc. Via Business Wire Our AI-Focused Drug Discovery Stocks Portfolio Was Up Almost 7% Last Week August 27, 2024 Via Talk Markets This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday August 20, 2024 Via Benzinga AI-Focused Drug Discovery Stocks Portfolio Hit Hard: Down 14% MTD August 14, 2024 Via Talk Markets AbCellera Biologics (ABCL) Q2 2024 Earnings Call Transcript August 07, 2024 Via The Motley Fool Topics Earnings Exposures Financial AbCellera Reports Q2 2024 Business Results August 06, 2024 From AbCellera Biologics Inc. Via Business Wire AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines July 31, 2024 From AbCellera Biologics Inc. Via Business Wire AI-Focused Drug Discovery Stocks Portfolio Up 7% Last Week; Up 19% MTD July 30, 2024 Via Talk Markets "Bubble" In AI/Semiconductor Stocks Began To Re-Inflate On Friday July 28, 2024 Via Talk Markets Billionaires Are Buying These 2 Beaten-Down Stocks. Are They Smart Buys for Your Portfolio? July 21, 2024 Via The Motley Fool AI-Powered Drug Discovery Stocks Portfolio Up 14% MTD; Still Down 30% YTD July 18, 2024 Via Talk Markets Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD July 14, 2024 Via Talk Markets 3 Biotech Stocks That Can Gain Exponentially By Leveraging AI July 02, 2024 Via Talk Markets AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024 June 25, 2024 From AbCellera Biologics Inc. Via Business Wire Largest Clinical-Stage BioTech Drug Stocks Declined 6% June 22, 2024 Via Talk Markets AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th June 17, 2024 Via Talk Markets Down 57%, Is AbCellera Biologics a Buy on the Dip? June 13, 2024 Via The Motley Fool AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week June 10, 2024 Via Talk Markets AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 May 28, 2024 From AbCellera Biologics Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
